Table 3 Model assumptions on costs
Cost Parameter | Value (RM) | Remarks |
|---|---|---|
PCV7 vaccination cost (per infant) | 888 | 4 dose regimen at current market price of RM222 per dose |
Pre-admission costs (adult and paediatric) | ||
Meningitis, pneumonia and otitis media | 206 | Focus group discussion |
Septicaemia | 309 | Â |
Post-discharge costs (adult and paediatric) | ||
Meningitis, pneumonia and otitis media | 309 | Focus group discussion |
Septicaemia | 1,236 | Â |
Paediatric cost per episode of hospitalised infection | ||
Pneumococcal bacteraemia | 7,076 | Â |
Pneumococcal meningitis | 5,399 | Â |
Hospitalised all-Cause pneumonia | 2,592 | Weighted average cost of treatment for each episode of disease calculated using data from 6 local hospitals |
Severe otitis media | 2,554 | Â |
Weighted cost per episode of IPD | 3,191 | Â |
Adult cost per episode of hospitalised infection | ||
Pneumococcal bacteraemia | 6,141 | Â |
Pneumococcal meningitis | 3,504 | Weighted average cost of treatment for each episode of disease calculated using data from 6 local hospitals |
Hospitalised all-Cause pneumonia | 2,830 | Â |
Weighted cost per episode of IPD | 3,768 | Â |
Discount rate on costs and outcomes | 3% | Â |
Building use life | 20 years | Â |
Building depreciation | 5% p.a. | Â |
Instrument and vehicle use life | 5 years | Â |
Instrument and vehicle depreciation | 20% p.a. | Â |